Recruiting nowPhase 2
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
Updated 2026-05-14 · NCT07523633See eligibility →
Sponsor
Clinical trials sponsored by Anders Fink-Jensen, MD, DMSci
Active studies whose public registry record names Anders Fink-Jensen, MD, DMSci as lead sponsor.
3active studies
2recruiting now
1countries represented
3largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.